A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

por Cui, Qingli, Hu, Yanhui, Ma, Dongyang, Liu, Huaimin
Publicado 2021

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance

por Cui, Qingli, Hu, Yanhui, Cui, Qingan, Wu, Daoyuan, Mao, Yuefeng, Ma, Dongyang, Liu, Huaimin
Publicado 2022

Key Targets and Molecular Mechanisms of Active Volatile Components of Rabdosia rubescens in Gastric Cancer Cells

por Hu, Yanhui, Cui, Qingli, Ma, Dongyang, Jin, Wenwen, Li, Yingyue, Zhang, Jianhua, Xu, Youqi
Publicado 2022

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer

por Cui, Qingli, Mao, Yuefeng, Wu, Daoyuan, Hu, Yanhui, Ma, Dongyang, Zhang, LiHan, Liu, Huaimin
Publicado 2022

Nanodrugs systems for therapy and diagnosis of esophageal cancer

por Zhang, Lihan, Li, Xing, Yue, Guangxing, Guo, Lihao, Hu, Yanhui, Cui, Qingli, Wang, Jia, Tang, Jingwen, Liu, Huaimin
Publicado 2023